Skip to main content
. 2022 Mar 23;10(4):497. doi: 10.3390/vaccines10040497

Figure 4.

Figure 4

Percentages of subjects with unsolicited adverse events (AE), serious adverse events (SAE), AE leading to study withdrawal, medically attended AEs, new onset chronic disease (NOCD), AE of special interest (AESI), or death from Day 1 through study termination.